These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 21730106)

  • 21. Developing genome and exome sequencing for candidate gene identification in inherited disorders: an integrated technical and bioinformatics approach.
    Coonrod EM; Durtschi JD; Margraf RL; Voelkerding KV
    Arch Pathol Lab Med; 2013 Mar; 137(3):415-33. PubMed ID: 22770468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole genome sequencing.
    Ng PC; Kirkness EF
    Methods Mol Biol; 2010; 628():215-26. PubMed ID: 20238084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in detecting genetic alterations and their association with human disease.
    Schwartz CE; Chen CF
    J Mol Biol; 2013 Nov; 425(21):3914-8. PubMed ID: 23876707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform.
    Summerer D; Schracke N; Wu H; Cheng Y; Bau S; Stähler CF; Stähler PF; Beier M
    Genomics; 2010 Apr; 95(4):241-6. PubMed ID: 20138981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The promise and challenges of next-generation genome sequencing for clinical care.
    Johansen Taber KA; Dickinson BD; Wilson M
    JAMA Intern Med; 2014 Feb; 174(2):275-80. PubMed ID: 24217348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple and efficient identification of rare recessive pathologically important sequence variants from next generation exome sequence data.
    Carr IM; Morgan J; Watson C; Melnik S; Diggle CP; Logan CV; Harrison SM; Taylor GR; Pena SD; Markham AF; Alkuraya FS; Black GC; Ali M; Bonthron DT
    Hum Mutat; 2013 Jul; 34(7):945-52. PubMed ID: 23554237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bar-coded, multiplexed sequencing of targeted DNA regions using the Illumina Genome Analyzer.
    Szelinger S; Kurdoglu A; Craig DW
    Methods Mol Biol; 2011; 700():89-104. PubMed ID: 21204029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.
    Barbieri CE; Demichelis F; Rubin MA
    Histopathology; 2012 Jan; 60(1):187-98. PubMed ID: 22212086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of exome sequencing in the search for genetic causes of rare disorders of copper metabolism.
    Fuchs SA; Harakalova M; van Haaften G; van Hasselt PM; Cuppen E; Houwen RH
    Metallomics; 2012 Jul; 4(7):606-13. PubMed ID: 22555275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-generation sequencing to identify genetic causes of cardiomyopathies.
    Norton N; Li D; Hershberger RE
    Curr Opin Cardiol; 2012 May; 27(3):214-20. PubMed ID: 22421630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing genomic medicine in pathology.
    Williams ES; Hegde M
    Adv Anat Pathol; 2013 Jul; 20(4):238-44. PubMed ID: 23752086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
    Cronin M; Ross JS
    Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy.
    Dutton-Regester K; Hayward NK
    Adv Pharmacol; 2012; 65():399-435. PubMed ID: 22959033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies to identify genes for complex disorders: a focus on bipolar disorder and chromosome 16p.
    Byerley W; Badner JA
    Psychiatr Genet; 2011 Aug; 21(4):173-82. PubMed ID: 20453718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in medical applications of whole exome/genome sequencing discoveries.
    Marian AJ
    Trends Cardiovasc Med; 2012 Nov; 22(8):219-23. PubMed ID: 22921985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic analysis of hereditary hematological disorders: overview].
    Yoshida K; Ogawa S
    Rinsho Ketsueki; 2015 Jul; 56(7):861-6. PubMed ID: 26251150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging DNA sequencing technologies for human genomic medicine.
    Strausberg RL; Levy S; Rogers YH
    Drug Discov Today; 2008 Jul; 13(13-14):569-77. PubMed ID: 18598911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research.
    Hochstenbach R; Buizer-Voskamp JE; Vorstman JA; Ophoff RA
    Cytogenet Genome Res; 2011; 135(3-4):174-202. PubMed ID: 22056632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.